1. Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy. (31st December 2022) Authors: Di Lorenzo, Antonino; Bolli, Elisabetta; Ruiu, Roberto; Ferrauto, Giuseppe; Di Gregorio, Enza; Avalle, Lidia; Savino, Aurora; Poggio, Pietro; Merighi, Irene Fiore; Riccardo, Federica; Brancaccio, Mara; Quaglino, Elena; Cavallo, Federica; Conti, Laura Journal: Oncoimmunology Issue: Volume 11:Number 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗